ARTV - Artiva Biotherapeutics, Inc.
2.08
-0.100 -4.808%
Share volume: 112,043
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.18
-0.10
-0.05%
Summary score
35%
Profitability
35%
Dept financing
43%
Liquidity
49%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-14.86%
Return on sales
-148.78%
Return on invested capital
0%
Total debt ratio
96.33%
Debt ratio change over timeo
0%
Current Ratio
11.31%
Quick Ratio
0%
Cash Position Ratio
3.29%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-14.86%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
96.33%
Debt ratio change over timeo
0%
Current Ratio
11.31%
Quick Ratio
0%
Cash Position Ratio
3.29%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-11.59%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
11.75%
Debt ratio change over time
0%
Current Ratio
13.93%
Quick Ratio
0%
Cash Position Ratio
2.49%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ARTV | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 18.97% | 6.3% | 14.13% |
| Return on assets | -14.86% | 3.05% | 3.04% | 13.28% |
| Return on sales | -148.78% | 29.08% | 27.81% | 1.7% |
| Return on invested capital | 0% | 5.17% | 3.5% | -46.9% |
| Profitability | 0% | 81% | 55% | 45% |
| Total debt ratio | 96.33% | 92.73% | 66.91% | 19.17% |
| Debt ratio change over time | 0% | 21.88% | 144.36% | -1.07% |
| Dept financing | 25% | 28% | 42% | 5% |
| Current Ratio | 11.31% | 1.25% | 1.34% | 0% |
| Quick Ratio | 0% | 0.92% | 1.18% | 0% |
| Cash Position Ratio | 3.29% | 0.44% | 0.54% | 0% |
| Liquididy | 46% | 14% | 10% | 66% |
| Short-term ratios | ARTV | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -14.86% | 2.68% | 3.48% | 0% |
| Return on sales | 0% | 21.68% | 28.93% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 38% | 50% | 0% |
| Total debt ratio | 96.33% | 92.96% | 66.32% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 24% | 17% | 0% |
| Current Ratio | 11.31% | 1.25% | 1.34% | 0% |
| Quick Ratio | 0% | 0.92% | 1.18% | 0% |
| Cash Position Ratio | 3.29% | 0.44% | 0.54% | 0% |
| Liquididy | 50% | 26% | 32% | 0% |
